Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Change in Acquisitions & Divestments (2016 - 2020)

Edesa Biotech's Change in Acquisitions & Divestments history spans 7 years, with the latest figure at $500000.0 for Q3 2020.

  • For Q3 2020, Change in Acquisitions & Divestments changed N/A year-over-year to $500000.0; the TTM value through Sep 2020 reached $500000.0, changed N/A, while the annual FY2020 figure was $500000.0, N/A changed from the prior year.
  • Change in Acquisitions & Divestments for Q3 2020 was $500000.0 at Edesa Biotech, up from -$4.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $5.0 million in Q1 2016 and bottomed at -$4.5 million in Q1 2019.
  • The 5-year median for Change in Acquisitions & Divestments is $2.0 million (2017), against an average of $2.0 million.
  • The largest annual shift saw Change in Acquisitions & Divestments skyrocketed 72432.73% in 2016 before it tumbled 550.0% in 2019.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $4.0 million in 2016, then crashed by 75.0% to $1.0 million in 2017, then skyrocketed by 350.0% to $4.5 million in 2018, then tumbled by 200.0% to -$4.5 million in 2019, then soared by 111.11% to $500000.0 in 2020.
  • Per Business Quant, the three most recent readings for EDSA's Change in Acquisitions & Divestments are $500000.0 (Q3 2020), -$4.5 million (Q1 2019), and $4.5 million (Q4 2018).